There have been 56 serious injuries reported related to this Class I recall. If you use Dexcom's continuous glucose ...

PillTrek, a tiny wireless smart capsule created by Caltech, provides real-time gut health data by detecting electrolytes, ...

Innovative stem cell therapy shows promise in restoring insulin production for severe type 1 diabetes patients.

FDA recalls Dexcom glucose monitors (G6, G7, ONE models) due to alert issues posing severe health risks. Read more here.

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Abbott on Thursday forecast third-quarter profit below Wall Street expectations and estimated about $200 million in annual tariff costs.

Abbott beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its medical devices, including continuous glucose monitors.

That silence around Type 1 diabetes is exactly what advocates and educators hope to change. In a move toward inclusivity and awareness, a new Barbie doll has been released, Barbie with Type 1 diabetes ...

Revenues from the company's medical devices segment grew 12% in the quarter, fueled by double-digit gains in diabetes care, heart failure, electrophysiology, and rhythm management, with continuous ...

Managing type 1 diabetes has a substantial impact on quality of life and psychological health. Indeed, insulin overdosing can ...

Yet exercise can sometimes be deceptive. Years before starting Virta Health, while cofounding the real-estate company Trulia, ...

Before an important meeting or when a big decision needs to be made, we often mentally run through various scenarios before ...